Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Semaglutide’s Heart Benefits May Extend Beyond Weight Loss

Researchers found only half of semaglutide’s 20% drop in serious cardiovascular events was tied to weight and other measured risk factors.

Summary by News Medical
Semaglutide is known to reduce the risk of serious heart disease. However, a new study published in the European Heart Journal today (Thursday) suggests that this effect cannot not be entirely explained by patients losing weight on the drug.

7 Articles

Right

It is known that semaglutide reduces the risk of severe heart disease; however, a new expert study from the University of Edinburgh (UK) published suggests that this effect cannot be fully explained by the weight loss patients experience when taking the drug. Researchers, who have published in ... Continue reading "Beyond weight loss: weight loss drugs reduce heart disease"

·Madrid, Spain
Read Full Article

The SELECT trial shows that semaglutide reduces cardiovascular episodes by 20%, but only 31 % of this effect is explained by thinning. La entrada Goodbye to myth: Ozempic semaglutide protects the heart without thinning aparece primero en Moncloa.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 75% of the sources are Center
75% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Medical Xpress broke the news in Douglas, United Kingdom on Wednesday, September 23, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal